Patent · US Expired

DNA encoding and methods of production of insulin-like growth factor binding protein BP53

US5258287A · kind A · utility

31Cited by

9References

20Claims

0Family size

Assignees

Genentech, Inc. · US
Central Sydney Area Health Service · AU

Inventors

Robert C. Baxter · Sydney, AU
William I. Wood · Hillsborough, US

Key dates

Filing date	Mar 22, 1988
Grant date	Nov 2, 1993
Priority date	—
Expiry date	Mar 22, 2008

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

DNA isolates coding for insulin-like growth factor binding protein may be used to produce the protein via recombinant expression systems. Insulin-like growth factor binding protein, which generally has a molecular weight of about 53 kD on non-reducing SDS-PAGE, is useful as a binder to insulin-like growth factor and as a metabolic regulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.